We use privacy-friendly analytics. Read our privacy policy.

Compound Profile

Andrographis

Andrographis has moderate human evidence for reducing upper respiratory tract infection symptoms.

Review needed — GI upset; rare allergic reactions. Details

Last reviewed: •1 source citedReport a correctionProfile-wide ·B Moderate
Andrographis monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade B
Safety
GI upset; rare allergic reactions.
Profile context
NF-κB, immune response pathways
Next steps

Continue reading

Quick stats

Evidence level
Moderate evidence
Typical onset
Varies by prep
Safety rating
Review needed: Safety review pending
Best for
NF κB, Immune Response Pathways
Avoid / review if
Pregnancy (Animal And Traditional Use Evidence Of Uterine Stimulant/Antifertility Effects), Known Acanthaceae Family Allergy, Anticoagulant/Antiplatelet Or Antihypertensive Therapy Without Monitoring

Safety

Safety & Cautions

GI upset; rare allergic reactions.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Stimulant-Like ProfileStimulant-like or activating caution language is present.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

147 flagged pairings

Bleeding / anticoagulant risk

Moderate Caution

191 flagged pairings

Blood-sugar lowering · Blood-pressure effects

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Evidence Summary

Profile-wide ·B Moderate

Evidence lens

Useful signal, but study design, dose, and population still matter.

ModerateModerate evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Immune Signaling Modulation · NF KB Modulation

Research maturity: Established research — main contexts: NF κB · Immune Response Pathways

Safety boundary: Safety note available — GI upset; rare allergic reactions.

This profile cites 1 human study.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Moderate evidence

Andrographis has a moderate evidence rating.

General wellnessGeneral wellness
Citation density
0.5
Sources
1
Effects
2
Research recency
Mixed recency
Evidence Grade

Grade B: Moderate Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Systematic review
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a systematic review, drawn from 2 recorded studies, 2 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (1)1 human evidence source · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

What the evidence actually shows

This table contains 1 structured source, including 1 human evidence source; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy

PubMed · Planta Med · 2004

Background
Systematic review

Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically.

——————PubMed →

How Andrographis Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Andrographis Works

How Andrographis WorksAndrographis acts on biological target pathways via anti inflammatory, leading to nf κb.AndrographisBiological TargetBiological pathwayAnti InflammatoryNf κBObservable outcomeImmune ModulationParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form
capsule or standardized extract
No standardized dose
Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Inflammatory Signaling Modulation
  • Immune Signaling Modulation
  • NF KB Modulation
  • Inflammatory

Guides that use Andrographis

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Andrographis evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Sourcing options

Andrographis product picks

Recommendation status

Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.

Product form & quality guidelines

When sourcing Andrographis, verify the label for:

  • Standardized Extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
  • Third-Party Testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
  • Form Bioavailability: Ensure the form matches evidence-supported configurations (e.g. chelated bisglycinate/glycinate for magnesium, micronized monohydrate for creatine) for optimal onset and digestion tolerance.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?